Hope and fear; Paxlovid for COVID-19 treatment: A Letter to the Editor

Q3 Medicine

Journal of Nephropharmacology Pub Date : 2022-07-08 DOI:10.34172/npj.2022.10485

Alireza Pouramini, M. Khosravian, Fatemeh Kafi, Sina Bakhshaei, H. Jahantigh, P. Peymani, N. Kianpour, M. Foroutan

引用次数: 0

Abstract

impairment. Additionally, Paxlovid requires Implication for health policy/practice/research/medical education: Paxlovid is an effective oral treatment for COVID-19 patients that reduces mortality and can be administered in an outpatient setting, but it cannot substitute COVID-19 immunizations.

查看原文本刊更多论文

希望和恐惧;Paxlovid用于治疗COVID-19:致编辑的一封信

障碍。此外，Paxlovid需要对卫生政策/实践/研究/医学教育的影响:Paxlovid是COVID-19患者有效的口服治疗药物，可降低死亡率，可在门诊环境中使用，但不能替代COVID-19免疫接种。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊